Market Cap 142.09B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.81
Forward PE 8.01
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 29,409,200
Avg Vol 67,806,570
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 10%
Beta 0.46
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
taxplanr
taxplanr Jan. 1 at 2:38 AM
15 States looking to ban malignantRNA jabs in 2026 $BNTX $MRNA $PFE https://www.instagram.com/reel/DS8scQJDUsU/?igsh=MWs4OWo0NDg1bHQxaQ==
0 · Reply
apux
apux Dec. 31 at 11:51 PM
$VNDA -- This is going to be a really interesting ride this year. I still think it gets bought out but reading this really illustrates the total addressible market for their drug. $LLY $PFE $NVO The approval of NEREUS™ for the prevention of vomiting induced by motion validates its pharmacological profile and paves the way for further exploration of NK-1 antagonism in related vomit-inducing conditions. Vanda is advancing tradipitant in clinical development for gastroparesis, a chronic disorder characterized by delayed gastric emptying and persistent nausea/vomiting, as well as for the prevention of nausea and vomiting induced by GLP-1 receptor agonists—a common side effect impacting adherence in the rapidly growing obesity and diabetes treatment landscape. Vanda anticipates launching NEREUS™ for the prevention of vomiting induced by motion in the coming months and remains committed to expanding its therapeutic potential across indications driven by substance P-mediated pathways.
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 11:38 PM
SNSE is Squeezing!!!! $FCX $PFE $CLSK $NUAI $BE K
1 · Reply
GoodTidings
GoodTidings Dec. 31 at 11:23 PM
$SLS Its clear there is a race of highest ownership of the stock... Who is behind it... Maybe BP? $MRK ? $PFE ? Or $MRK Hostile takeover? 🤔🤔🤔
0 · Reply
Jamessmithy
Jamessmithy Dec. 31 at 10:37 PM
0 · Reply
Mukulu2025
Mukulu2025 Dec. 31 at 9:57 PM
$PFE Time to shake off this inertia and move up in the new year in earnest. Added at close.
0 · Reply
Longbuy1
Longbuy1 Dec. 31 at 9:45 PM
$SLS $PFE $MRK $ABBV ABBV MRK PFE one of your companies is going to buy SLS for 10bil, shares will just converted. Float is 217M with all warrants exercised. Go buy some discounted shares. $GME you can meme SLS now market cap is about 500M. Easy 20-30 bagger that's the floor.
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 9:42 PM
SNSE is the Next big Retail Squeeze!! $IVP $UBER $PFE $VRT $TTD F
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 9:18 PM
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 31 at 8:25 PM
$PFE it’s just so blatant
1 · Reply
Latest News on PFE
Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 12 days ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound


Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 14 days ago

Pfizer Stock Can Sink More. Here Is How


Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 15 days ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript


Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 15 days ago

Pfizer falls on disappointing guidance


Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 15 days ago

Here's why Pfizer is revising its revenue forecasts


Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 19 days ago

Pfizer Declares First-Quarter 2026 Dividend


Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 26 days ago

Pfizer: The Market Is Still Wrong About It


Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Nov 30, 2025, 6:13 AM EST - 4 weeks ago

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters


Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 5 weeks ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY


Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 5 weeks ago

Pfizer Crosses Below Key Moving Average Level


taxplanr
taxplanr Jan. 1 at 2:38 AM
15 States looking to ban malignantRNA jabs in 2026 $BNTX $MRNA $PFE https://www.instagram.com/reel/DS8scQJDUsU/?igsh=MWs4OWo0NDg1bHQxaQ==
0 · Reply
apux
apux Dec. 31 at 11:51 PM
$VNDA -- This is going to be a really interesting ride this year. I still think it gets bought out but reading this really illustrates the total addressible market for their drug. $LLY $PFE $NVO The approval of NEREUS™ for the prevention of vomiting induced by motion validates its pharmacological profile and paves the way for further exploration of NK-1 antagonism in related vomit-inducing conditions. Vanda is advancing tradipitant in clinical development for gastroparesis, a chronic disorder characterized by delayed gastric emptying and persistent nausea/vomiting, as well as for the prevention of nausea and vomiting induced by GLP-1 receptor agonists—a common side effect impacting adherence in the rapidly growing obesity and diabetes treatment landscape. Vanda anticipates launching NEREUS™ for the prevention of vomiting induced by motion in the coming months and remains committed to expanding its therapeutic potential across indications driven by substance P-mediated pathways.
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 11:38 PM
SNSE is Squeezing!!!! $FCX $PFE $CLSK $NUAI $BE K
1 · Reply
GoodTidings
GoodTidings Dec. 31 at 11:23 PM
$SLS Its clear there is a race of highest ownership of the stock... Who is behind it... Maybe BP? $MRK ? $PFE ? Or $MRK Hostile takeover? 🤔🤔🤔
0 · Reply
Jamessmithy
Jamessmithy Dec. 31 at 10:37 PM
0 · Reply
Mukulu2025
Mukulu2025 Dec. 31 at 9:57 PM
$PFE Time to shake off this inertia and move up in the new year in earnest. Added at close.
0 · Reply
Longbuy1
Longbuy1 Dec. 31 at 9:45 PM
$SLS $PFE $MRK $ABBV ABBV MRK PFE one of your companies is going to buy SLS for 10bil, shares will just converted. Float is 217M with all warrants exercised. Go buy some discounted shares. $GME you can meme SLS now market cap is about 500M. Easy 20-30 bagger that's the floor.
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 9:42 PM
SNSE is the Next big Retail Squeeze!! $IVP $UBER $PFE $VRT $TTD F
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 9:18 PM
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 31 at 8:25 PM
$PFE it’s just so blatant
1 · Reply
barnml2006
barnml2006 Dec. 31 at 8:15 PM
$PFE Guess I'll have to DCA down soon.
0 · Reply
Makingmillions192
Makingmillions192 Dec. 31 at 8:04 PM
$LEXX Go give it a upvote if you can!! https://www.reddit.com/r/pennystocks/s/4YIcdKNkly $NVO $PFE $JAZZ
0 · Reply
MHM7700
MHM7700 Dec. 31 at 8:03 PM
$PFE 1/9 25c $0.23
0 · Reply
jhop123
jhop123 Dec. 31 at 7:39 PM
0 · Reply
Longbuy1
Longbuy1 Dec. 31 at 7:13 PM
$SLS where only 41$ short of target value 45$. Question is when $PFE $ABBV $MRK buys us. $GME meme people can still jump in for a 20x bagger.
0 · Reply
Offender
Offender Dec. 31 at 5:45 PM
$PFE $25 all week 😂
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Dec. 31 at 5:35 PM
$PFE nice cup build intraday action
1 · Reply
sister
sister Dec. 31 at 5:32 PM
$MRNA $PFE can always get cheaper . . . $NVO too
2 · Reply
JustinTeel993
JustinTeel993 Dec. 31 at 5:23 PM
$TTE $PFE $BSX $UNP $RIO Nicely captured
0 · Reply
YoloAlfred
YoloAlfred Dec. 31 at 5:18 PM
$PFE $T & $PFE will both break $30 in 2026
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Dec. 31 at 4:43 PM
$PFE building positions under 25 will pay nicely in 2026 and beyond with Pfizer imo
0 · Reply
dom04
dom04 Dec. 31 at 4:42 PM
$PFE triple bottom rejection daily at 24,90$ if it hold, could be a strong bullish reversal toward 26$. Waiting this pm to buy this swing trade.
0 · Reply